Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of cytochrome P4501A enzymes

Journal of Pharmacology and Experimental Therapeutics

Volumn 339, Issue 1, 2011, Pages 106-114

  Shivanna, Binoy ^a   Jiang, Weiwu ^a   Wang, Lihua ^a   Couroucli, Xanthi I ^a   Moorthy, Bhagavatula ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A; LIVER ENZYME; LUNG ENZYME; OMEPRAZOLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPEROXIC LUNG INJURY; IN VIVO STUDY; LUNG INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ACUTE LUNG INJURY; ANIMALS; BLOTTING, WESTERN; CHEMOKINE CCL2; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; ENZYME INHIBITORS; HYPEROXIA; IMMUNOHISTOCHEMISTRY; LIVER; LUNG; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED STRAINS; MICROSOMES; NEUTROPHIL INFILTRATION; OMEPRAZOLE; ORGAN SIZE; PULMONARY ALVEOLI; PULMONARY EDEMA; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80053159514     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.182980     Document Type: Article

References (40)

1. Baraldi E and Filippone M (2007) Chronic lung disease after premature birth. N Engl J Med 357:1946-1955. (Pubitemid 350074689)
2. Burke MD, Thompson S, Weaver RJ, Wolf CR, and Mayer RT (1994) Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol 48:923-936. (Pubitemid 24285170)
3. Cadir FO, Bicakci U, Tander B, Kilicoglu-Aydin B, Rizalar R, Ariturk E, Aydin O, and Bernay F (2008) Protective effects of vitamin E and omeprazole on the hypoxia/reoxygenation induced intestinal injury in newborn rats. Pediatr Surg Int 24:809-813.
4. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159. (Pubitemid 17064313)
5. Clark JM and Lambertsen CJ (1971) Pulmonary oxygen toxicity: a review. Pharmacol Rev 23:37-133.
6. Couroucli XI, Welty SE, Geske RS, and Moorthy B (2002) Regulation of pulmonary and hepatic cytochrome P4501A expression in the rat by hyperoxia: implications for hyperoxic lung injury. Mol Pharmacol 61:507-515. (Pubitemid 34171916)
7. Denison MS and Nagy SR (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43:309-334. (Pubitemid 37372644)
8. Diaz D, Fabre I, Daujat M, Saint Aubert B, Bories P, Michel H, and Maurel P (1990) Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology 99:737-747. (Pubitemid 20243366)
9. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, Bauer CR, Donovan EF, Korones SB, Laptook AR, et al. (2007) Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 196:147, e1-8.
10. Freeman BA and Crapo JD (1981) Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem 256:10986-10992. (Pubitemid 12181585)
11. Gonder JC, Proctor RA, and Will JA (1985) Genetic differences in oxygen toxicity are correlated with cytochrome P-450 inducibility. Proc Natl Acad Sci USA 82:6315-6319. (Pubitemid 16222875)
12. Guengerich FP (1990) Enzymatic oxidation of xenobiotic chemicals. Crit Rev Biochem Mol Biol 25:97-153.
13. Halliwell B, Zhao K, and Whiteman M (2000) The gastrointestinal tract: a major site of antioxidant action? Free Radic Res 33:819-830. (Pubitemid 32208490)
14. Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12(Suppl 1):S3-S9.
15. Jiang W, Welty SE, Couroucli XI, Barrios R, Kondraganti SR, Muthiah K, Yu L, Avery SE, and Moorthy B (2004) Disruption of the Ah receptor gene alters the susceptibility of mice to oxygen-mediated regulation of pulmonary and hepatic cytochromes P4501A expression and exacerbates hyperoxic lung injury. J Pharmacol Exp Ther 310:512-519. (Pubitemid 38988894)
16. Kashfi K, McDougall CJ, and Dannenberg AJ (1995) Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat and human. Clin Pharmacol Ther 58:625-630. (Pubitemid 26020702)
17. Kobayashi T, Ohta Y, Inui K, Yoshino J, and Nakazawa S (2002) Protective effect of omeprazole against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Pharmacol Res 46:75-84. (Pubitemid 35300796)
18. Krusekopf S, Kleeberg U, Hildebrandt AG, and Ruckpaul K (1997) Effects of benzimidazole derivatives on cytochrome P450 1A1 expression in a human hepatoma cell line. Xenobiotica 27:1-9. (Pubitemid 27068368)
19. Larsson H, Carlsson E, Junggren U, Olbe L, Sjöstrand SE, Skånberg I, and Sundell G (1983) Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 85:900-907. (Pubitemid 13000644)
20. Larsson H, Carlsson E, Ryberg B, Fryklund J, and Wallmark B (1988) Rat parietal cell function after prolonged inhibition of gastric acid secretion. Am J Physiol Gastrointest Liver Physiol 254:G33-G39.
21. Li XQ, Andersson TB, Ahlström M, and Weidolf L (2004) Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos 32:821-827. (Pubitemid 38955611)
22. Lind T, Cederberg C, Ekenved G, Haglund U, and Olbe L (1983) Effect of omeprazole - a gastric proton pump inhibitor-on pentagastrin stimulated acid secretion in man. Gut 24:270-276. (Pubitemid 13159786)
23. Mansour H, Levacher M, Azoulay-Dupuis E, Moreau J, Marquetty C, and Gougerot-Pocidalo MA (1988) Genetic differences in response to pulmonary cytochrome P-450 inducers and oxygen toxicity. J Appl Physiol 64:1376-1381.
24. Moorthy B (2008) The CYP1A subfamily, in Cytochromes P450 Role in Drug Metabolism and Toxicity of Drugs and Other Xenobiotics (Ioannides C, ed) pp 97-135, RSC Publishing, Cambridge, UK.
25. Moorthy B, Nguyen UT, Gupta S, Stewart KD, Welty SE, and Smith CV (1997) Induction and decline of hepatic cytochromes P4501A1 and 1A2 in rats exposed to hyperoxia are not paralleled by changes in glutathione S-transferase-α. Toxicol Lett 90:67-75. (Pubitemid 27046515)
26. Moorthy B, Parker KM, Smith CV, Bend JR, and Welty SE (2000) Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole. J Pharmacol Exp Ther 292:553-560. (Pubitemid 30067418)
27. Nebert DW, Dalton TP, Okey AB, and Gonzalez FJ (2004) Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279:23847-23850. (Pubitemid 38725238)
28. Park EY and Rho HM (2002) The transcriptional activation of the human copper/zinc superoxide dismutase gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin through two different regulator sites, the antioxidant responsive element and xenobiotic responsive element. Mol Cell Biochem 240:47-55. (Pubitemid 35385819)
29. Pozzoli C, Menozzi A, Grandi D, Solenghi E, Ossiprandi MC, Zullian C, Bertini S, Cavestro GM, and Coruzzi G (2007) Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine. Naunyn Schmiedebergs Arch Pharmacol 374:283-291. (Pubitemid 46089466)
30. Shertzer HG, Clay CD, Genter MB, Schneider SN, Nebert DW, and Dalton TP (2004) Cyp1a2 protects against reactive oxygen production in mouse liver microsomes. Free Radic Biol Med 36:605-617. (Pubitemid 38230177)
31. Shih H, Pickwell GV, Guenette DK, Bilir B, and Quattrochi LC (1999) Species differences in hepatocyte induction of CYP1A1 and CYP1A2 by omeprazole. Hum Exp Toxicol 18:95-105. (Pubitemid 29087950)
32. Short EJ, Klein NK, Lewis BA, Fulton S, Eisengart S, Kercsmar C, Baley J, and Singer LT (2003) Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 112:e359.
33. Sinal CJ, Webb CD, and Bend JR (1999) Differential in vivo effects of α-naphthoflavone and β-naphthoflavone on CYP1A1 and CYP2E1 in rat liver, lung, heart, and kidney. J Biochem Mol Toxicol 13:29-40. (Pubitemid 129709401)
34. Sinha A, Muthiah K, Jiang W, Couroucli X, Barrios R, and Moorthy B (2005) Attenuation of hyperoxic lung injury by the CYP1A inducer β- naphthoflavone. Toxicol Sci 87:204-212. (Pubitemid 41222673)
35. Tompkins LM and Wallace AD (2007) Mechanisms of cytochrome P450 induction. J Biochem Mol Toxicol 21:176-181. (Pubitemid 350194377)
36. Tong V, Chang TK, Chen J, and Abbott FS (2003) The effect of valproic acid on hepatic and plasma levels of 15-F2t-isoprostane in rats. Free Radic Biol Med 34:1435-1446. (Pubitemid 36570417)
37. Wandall JH (1992) Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. Gut 33:617-621.
38. Wei C, Caccavale RJ, Weyand EH, Chen S, and Iba MM (2002) Induction of CYP1A1 and CYP1A2 expressions by prototypic and atypical inducers in the human lung. Cancer Lett 178:25-36. (Pubitemid 34159238)
39. Yoshida N, Yoshikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y, and Kondo M (2000) A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther 14(Suppl 1):74-81. (Pubitemid 30199109)
40. Yoshinari K, Ueda R, Kusano K, Yoshimura T, Nagata K, and Yamazoe Y (2008) Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements. Biochem Pharmacol 76:139-145.